drugset / Trial / NCT01504724
Effect of the Adjunctive IVB Before PRP
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to investigate the effect of adjunctive intravitreal bevacizumab (IVB) before panretinal photocoagulation (PRP) compared with only PRP on central macular thickness and retinal nerve fiber layer thickness in patients with severe diabetic retinopathy without macular edema.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |